Gregory J. Fleming, President & CEO of Rockefeller Capital Management, spoke with returning guest, Dr. Jason Kelly, Co-Founder and CEO of Ginkgo Bioworks, for a Uniquely Rockefeller Special Client Event entitled The Latest on COVID-19 Testing: A Conversation with Dr. Jason Kelly, Co-founder and CEO of Ginkgo Bioworks. The conversation spanned a wide range of topics that included what the team at Ginkgo Bioworks is doing to assist schools, workplaces, and communities in the effort to track and contain COVID-19 spread.